95 related articles for article (PubMed ID: 21962192)
1. Inner canthus hypertrichosis: a side effect of prostaglandin analogue treatment for glaucoma.
Monselise A; Shapiro J; Lui H
J Cutan Med Surg; 2011; 15(5):298-9. PubMed ID: 21962192
[No Abstract] [Full Text] [Related]
2. Eyelash hypertrichosis in a patient treated with topical latanoprost.
Strober BE; Potash S; Grossman ME
Cutis; 2001 Feb; 67(2):109-10. PubMed ID: 11236218
[TBL] [Abstract][Full Text] [Related]
3. Hypertrichosis and increased pigmentation of eyelashes and adjacent hair in the region of the ipsilateral eyelids of patients treated with unilateral topical latanoprost.
Johnstone MA
Am J Ophthalmol; 1997 Oct; 124(4):544-7. PubMed ID: 9323945
[TBL] [Abstract][Full Text] [Related]
4. Eyelash formation secondary to latanoprost treatment in a patient with alopecia.
Mansberger SL; Cioffi GA
Arch Ophthalmol; 2000 May; 118(5):718-9. PubMed ID: 10815168
[No Abstract] [Full Text] [Related]
5. Topical prostaglandin F(2alpha) analog induced poliosis.
Chen CS; Wells J; Craig JE
Am J Ophthalmol; 2004 May; 137(5):965-6. PubMed ID: 15126178
[TBL] [Abstract][Full Text] [Related]
6. [Side-effects and risk profile of latanoprost 0.005% (Xalatan)].
Schlote T
Ophthalmologe; 2002 Sep; 99(9):724-9. PubMed ID: 12219263
[TBL] [Abstract][Full Text] [Related]
7. Prostaglandin-induced hair growth.
Johnstone MA; Albert DM
Surv Ophthalmol; 2002 Aug; 47 Suppl 1():S185-202. PubMed ID: 12204716
[TBL] [Abstract][Full Text] [Related]
8. Promising alternative clinical uses of prostaglandin F2α analogs: beyond the eyelashes.
Choi YM; Diehl J; Levins PC
J Am Acad Dermatol; 2015 Apr; 72(4):712-6. PubMed ID: 25601618
[TBL] [Abstract][Full Text] [Related]
9. Hypertrichosis of the eyelashes from prostaglandin analog use: a blessing or a bother to the patient?
Shaikh MY; Bodla AA
J Ocul Pharmacol Ther; 2006 Feb; 22(1):76-7. PubMed ID: 16503779
[No Abstract] [Full Text] [Related]
10. Lash ptosis caused by latanoprost.
Casson RJ; Selva D
Am J Ophthalmol; 2005 May; 139(5):932-3. PubMed ID: 15860312
[TBL] [Abstract][Full Text] [Related]
11. [Latanoprost--a new prostaglandin F2 alpha analog in therapy of glaucoma--an overview].
Erb C; Messerli J; Flammer J
Klin Monbl Augenheilkd; 1998 Jan; 212(1):2-12. PubMed ID: 9541888
[TBL] [Abstract][Full Text] [Related]
12. Studies on ocular inflammation and development of a prostaglandin analogue for glaucoma treatment.
Stjernschantz J
Exp Eye Res; 2004 Apr; 78(4):759-66. PubMed ID: 15037110
[TBL] [Abstract][Full Text] [Related]
13. Hypertrichosis of the malar areas and poliosis of the eyelashes caused by latanoprost.
Özyurt S; Çetinkaya GS
Actas Dermosifiliogr; 2015; 106(1):74-5. PubMed ID: 25065768
[No Abstract] [Full Text] [Related]
14. Hypertrichosis of vellus hairs of the malar region after unilateral treatment with bimatoprost.
Hart J; Shafranov G
Am J Ophthalmol; 2004 Apr; 137(4):756-7. PubMed ID: 15059720
[TBL] [Abstract][Full Text] [Related]
15. [Glaucoma therapy with prostaglandin F2 alpha derivatives].
Diestelhorst M
Ophthalmologe; 1997 Oct; 94(10):754-69. PubMed ID: 9432248
[No Abstract] [Full Text] [Related]
16. Five-year, multicenter safety study of fixed-combination latanoprost/timolol (Xalacom) for open-angle glaucoma and ocular hypertension.
Alm A; Grunden JW; Kwok KK
J Glaucoma; 2011; 20(4):215-22. PubMed ID: 20520568
[TBL] [Abstract][Full Text] [Related]
17. [Side effects of antiglaucoma eye drops].
Otori Y
Nippon Ganka Gakkai Zasshi; 2006 Aug; 110(8):571-3. PubMed ID: 16972647
[No Abstract] [Full Text] [Related]
18. Observations on Prostaglandin Orbitopathy.
Custer PL; Kent TL
Ophthalmic Plast Reconstr Surg; 2016; 32(2):102-5. PubMed ID: 25719374
[TBL] [Abstract][Full Text] [Related]
19. A prospective study of iridial pigmentation and eyelash changes due to ophthalmic treatment with latanoprost.
Chiba T; Kashiwagi K; Ishijima K; Furuichi M; Kogure S; Abe K; Chiba N; Tsukahara S
Jpn J Ophthalmol; 2004; 48(2):141-7. PubMed ID: 15060793
[TBL] [Abstract][Full Text] [Related]
20. A topical prostaglandin for glaucoma.
Med Lett Drugs Ther; 1996 Nov; 38(987):100-1. PubMed ID: 8914508
[No Abstract] [Full Text] [Related]
[Next] [New Search]